These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7192994)

  • 41. Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats.
    Tyroller S; Zwickenpflug W; Thalheim C; Richter E
    Toxicology; 2005 Nov; 215(3):245-53. PubMed ID: 16118032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and metabolism of indoprofen in the hamster.
    Goldaniga GC; Montesanti L; Moro E; Pianezzola E; Valzelli G
    Arzneimittelforschung; 1980; 30(10):1654-8. PubMed ID: 7192105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biologic availability of vincamine from tablets with a hydrophilic matrix. II].
    Rolland A; Gibassier D; Chemtob C; Le Verge R
    J Pharm Belg; 1984; 39(3):136-44. PubMed ID: 6481608
    [No Abstract]   [Full Text] [Related]  

  • 44. Metabolism and disposition of moxonidine in Fischer 344 rats.
    He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
    Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biotransformation of 3-(2',4',5'-triethoxybenzoyl) propionic acid, a new biliary smooth muscle relaxant with choleretic activity, in rats.
    Kobayashi T; Tanayama S; Kanai Y
    Xenobiotica; 1978 Sep; 8(9):535-45. PubMed ID: 695697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biopharmaceutic and pharmacokinetic aspects of vincamine HCl.
    Ritschel WA; Agrawala P
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):129-36. PubMed ID: 4010386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
    Lee J; Son J; Rhee SW; Kim DH
    Xenobiotica; 2003 Jul; 33(7):755-65. PubMed ID: 12893524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
    Halpin RA; Ulm EH; Till AE; Kari PH; Vyas KP; Hunninghake DB; Duggan DE
    Drug Metab Dispos; 1993; 21(6):1003-11. PubMed ID: 7905377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Boyd SA; Uchic JT; Stein H; Cepa S; Hill P
    Drug Metab Dispos; 1994; 22(6):880-8. PubMed ID: 7895605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excretion of metabolites in urine and faeces from rats dosed with the heterocyclic amine, 2-amino-9H-pyrido[2,3-b]indole (AalphaC).
    Frederiksen H; Frandsen H
    Food Chem Toxicol; 2004 Jun; 42(6):879-85. PubMed ID: 15110096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats.
    Lan SJ; Hsieh DC; Hillyer JW; Fancher RM; Rinehart KJ; Warrack BM; White RE
    Drug Metab Dispos; 1998 Oct; 26(10):993-1000. PubMed ID: 9763405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absorption, distribution and excretion of DL-gamma-amino-beta-hydroxybutyric acid-1-14C (GABOB-1-14C) in the rat.
    Bonardi G; Mondino A; Silvestri S; Zanolo G
    Arzneimittelforschung; 1981; 31(11):1910-3. PubMed ID: 7198473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of metergoline in the rat.
    Vicario GP; Battaglia R; Bernardi L; Arcamone F
    Farmaco Sci; 1982 Oct; 37(10):651-62. PubMed ID: 7140965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo and in vitro metabolism of [14C]penicillic acid.
    Park DL; Friedman L; Heath JL
    J Environ Pathol Toxicol; 1980 Aug; 4(1):419-34. PubMed ID: 7441125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolism and disposition of n-butyl glycidyl ether in F344 rats and B6C3F1 mice.
    Chen LJ; Lebetkin EH; Nwakpuda EI; Burka LT
    Drug Metab Dispos; 2007 Dec; 35(12):2218-24. PubMed ID: 17875671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.